ATE348102T1 - Verfahren zur herstellung von oxycodon - Google Patents

Verfahren zur herstellung von oxycodon

Info

Publication number
ATE348102T1
ATE348102T1 AT05776280T AT05776280T ATE348102T1 AT E348102 T1 ATE348102 T1 AT E348102T1 AT 05776280 T AT05776280 T AT 05776280T AT 05776280 T AT05776280 T AT 05776280T AT E348102 T1 ATE348102 T1 AT E348102T1
Authority
AT
Austria
Prior art keywords
oxycodone
formula
hydroxycodeinone
hydrogen
peroxoacids
Prior art date
Application number
AT05776280T
Other languages
English (en)
Inventor
Vladislav Snuparek
Lubica Ratkovska
Bohumil Proksa
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE348102T1 publication Critical patent/ATE348102T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT05776280T 2004-08-18 2005-08-16 Verfahren zur herstellung von oxycodon ATE348102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK321-2004A SK286087B6 (sk) 2004-08-18 2004-08-18 Spôsob prípravy oxykodonu

Publications (1)

Publication Number Publication Date
ATE348102T1 true ATE348102T1 (de) 2007-01-15

Family

ID=34993096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05776280T ATE348102T1 (de) 2004-08-18 2005-08-16 Verfahren zur herstellung von oxycodon

Country Status (15)

Country Link
US (1) US7619087B2 (de)
EP (1) EP1658293B1 (de)
AT (1) ATE348102T1 (de)
CZ (1) CZ2005507A3 (de)
DE (1) DE602005000334T2 (de)
DK (1) DK1658293T3 (de)
EA (1) EA009392B1 (de)
ES (1) ES2273328T3 (de)
NO (1) NO20060476L (de)
PL (1) PL1658293T3 (de)
PT (1) PT1658293E (de)
SI (1) SI1658293T1 (de)
SK (1) SK286087B6 (de)
UA (1) UA86094C2 (de)
WO (1) WO2006019364A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5923827B2 (ja) * 1981-12-16 1984-06-05 フエザ−安全剃刀株式会社 安全かみそり刃
EP2032579A2 (de) * 2006-05-25 2009-03-11 Alpharma (Bermuda) Investments Ltd Für die herstellung von morphinanantagonisten geeignetes verfahren
KR100780932B1 (ko) * 2006-05-30 2007-11-30 엠텍비젼 주식회사 컬러 보간 방법 및 장치
US7906647B2 (en) 2006-12-04 2011-03-15 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
AU2007329451B2 (en) * 2006-12-04 2012-08-30 Noramco, Llc Process for reducing impurities in oxycodone base
CA2681740A1 (en) † 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
GB2450691A (en) * 2007-07-02 2009-01-07 Alpharma Aps One-pot preparation of oxycodone from thebaine
CA2737257C (en) * 2008-09-18 2016-11-15 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(.epsilon.-caprolactone)
EP2377866B1 (de) 2010-03-23 2014-02-26 Siegfried AG Herstellung von opiaten hoher reinheit in einem durchflussreaktor
CA2804101C (en) * 2010-07-02 2021-01-19 Johnson Matthey Public Limited Company Process for the synthesis and purification of oxycodone
TWI588147B (zh) * 2012-07-16 2017-06-21 羅德科技公司 改良之類鴉片合成方法
SG11201407988UA (en) * 2012-07-16 2015-01-29 Rhodes Technologies Process for improved opioid synthesis
HUE042762T2 (hu) * 2012-08-03 2019-07-29 Johnson Matthey Plc Eljárás oxikodon elõállítására
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
WO2015095585A2 (en) * 2013-12-18 2015-06-25 Cody Laboratories, Inc. Sysnthesis of oxycodone hydrochloride
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
WO2015107471A1 (en) 2014-01-15 2015-07-23 Rhodes Technologies Process for improved oxycodone synthesis
CA2937007C (en) 2014-01-15 2018-11-06 Rhodes Technologies Process for improved oxymorphone synthesis
US20160052932A1 (en) 2014-08-25 2016-02-25 Johnson Matthey Public Limited Company Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone
WO2016100113A2 (en) * 2014-12-17 2016-06-23 Siemens Healthcare Diagnostics Inc. Conjugates for assays for oxycodone and oxymorphone
EP4122933A1 (de) * 2017-06-20 2023-01-25 Johnson Matthey Public Limited Company Hydrierungsverfahren zur herstellung von oxycodon-hydrochlorid aus 14-hydroxycodeinon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6864370B1 (en) * 2003-06-05 2005-03-08 Zhaiwei Lin Process for manufacturing oxycodone

Also Published As

Publication number Publication date
PL1658293T3 (pl) 2007-03-30
US20070088162A1 (en) 2007-04-19
EP1658293B1 (de) 2006-12-13
SK286087B6 (sk) 2008-03-05
SI1658293T1 (sl) 2007-04-30
ES2273328T3 (es) 2007-05-01
EA200600129A1 (ru) 2006-06-30
NO20060476L (no) 2006-03-14
SK3212004A3 (sk) 2006-03-02
EP1658293A1 (de) 2006-05-24
EA009392B1 (ru) 2007-12-28
US7619087B2 (en) 2009-11-17
DE602005000334T2 (de) 2007-04-12
PT1658293E (pt) 2007-01-31
DK1658293T3 (da) 2007-01-29
CZ2005507A3 (cs) 2007-01-31
WO2006019364A1 (en) 2006-02-23
UA86094C2 (en) 2009-03-25
DE602005000334D1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
ATE348102T1 (de) Verfahren zur herstellung von oxycodon
CA2598774A1 (en) Method of reducing alpha, beta unsaturated ketones in opioid compositions
NZ601326A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
EP2428519A3 (de) Verfahren zur Herstellung von 17-Vinyl-Triflate als Zwischenprodukte
AU2011231748B2 (en) Preparation of low impurity opiates in a continuous flow reactor
RU2010126906A (ru) Способ получения производного индолинона
EP1829863A4 (de) Arylalkansäurederivat
RU2012105460A (ru) Новые карбаматные и пептидные пролекарства опиоидов и их использование
GB0418900D0 (en) Novel salt forms
TW200619182A (en) The magnesium compounds, the solid catalyst components, the olefin polymerization catalyst, and the method for producing polyolefin
EA022994B1 (ru) Способ подавления толерантности к опиоидному анальгетику
NZ625798A (en) Processes for the manufacture of a pharmaceutically active agent
JP4532109B2 (ja) 新規オリパビン誘導体および医薬としてのその使用
RU2007122353A (ru) Способ получения гидробромида галантамина
CY1111445T1 (el) Μεθοδος παρασκευης ισοτονης υδατικης ενεσης ροπιβακαϊνης
ATE245624T1 (de) Verfahren zur herstellung substituierter allylamin derivative und deren salze
NO20053176L (no) Fremgangsmate for fremstilling av tolperisonsalter.
DE602006015241D1 (de) Verbessertes verfahren zur herstellung von rivastigmin
BRPI0510313A (pt) compostos como antagonistas de ccr1
ATE403418T1 (de) Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid
MXPA05007217A (es) Proceso para la preparacion de derivados de imidazol sustituidos y los productos intermedios usados en este proceso.
ATE402139T1 (de) Verfahren zur herstellung von aziminoethern
EA200501135A1 (ru) Способы получения алкалоидов хиназолина
RU2009108734A (ru) Способ получения производных n-метиладамантила посредством катализируемой палладием реакции сочетания с последующим восстановительным аминированием
DE60215249D1 (de) Verfahren zur Herstellung der 2-(dimethylamino)-1-(dimethylaminomethyl)ethyle-(methyl)acrylat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1658293

Country of ref document: EP

REN Ceased due to non-payment of the annual fee